#CX2024 : Stephen Greenhalgh kicks off the CX Symposium Dragons' Den crucible of medical innovation. Vascular News Venus Isfahan

#CX2024 : Leadership Challenges session set to commence at CX Symposium featuring Vascular Girl. WFVS svs

#CX2024 : Stephen Black delivers a @cxsymposium podium first focused on the need for an inferior vena cava stent, and the investigational Gore Viafort venous stent of which he is a PI.

#CX2024 : Andrew Bradbury sums up the BASIL-3 findings, which are ' likely to be a realistic representation' of what can be expected to be seen across the NHS in the UK, he says.

#CX2024 : Drug-coated balloons are unlikely to be cost effective at the current willingness to pay in the UK but drug eluting stents potentially are, according the BASIL-3 findings, says Andrew Bradbury.

#CX2024 : The BASIL-3 researchers led by Andrew Bradbury reveals the top line results from BASIL-3 CX Symposium.

.Eric Secemsky MD MSc reports that the meta-analysis and regulatory restrictions on #paclitaxel devices did cause patient harm, with higher major amputation and death in US #PAD patients in the post-paclitaxel controversy period #CX2024

In this afternoon’s Inaugural Roger M Greenhalgh Late Breaking Trials Session at #CX2024 , Anahita Dua MD MS MBA FACS shares new data from the CLariTI study CX Symposium LimFlow SA

Increased #paclitaxel mortality signal “wrong from the start” and data show no negative association between dose and mortality, reports Thomas Zeller #CX2024 CX Symposium

CX2024: Brian DeRubertis delivers the latest data from the LIFE-BTK trial CX Symposium.

‘Following the U.S. FDA announcement, paclitaxel-coated devices now beat limus devices’ - Marianne Brodmann and Andrew Holden argue for and against the motion respectively, Brodmann showing benefits but noting #PTX wins out for now due to “missing” limus data to date #CX2024

“Unfortunately, we are doing worse for our patients today,” were the sobering thoughts of Eric Secemsky MD MSc (Boston, United States) during a late-breaking presentation on whether #paclitaxel device restrictions have caused patient harm

#CX2024 CX Symposium
tinyurl.com/ye37jebc

#CX2024 welcomes a revolutionised Carotid and Acute Stroke programme (Wednesday 24 April) which, for the first time, expands upon carotid indications, new technologies and neurointeventions.

🆕 this year is the Carotid Workshop Day (Thursday 25 April)!

The April issue of Vascular Specialist Online is available online now: vascularspecialistonline.com/vascular-speci…

Includes: Matthew Smeds Ron Dalman Andrew Bradbury Zach AbuRahma danny bertges Chris Audu MD, PhD Brigitte K. Smith, MD, MHPE Bijan Modarai and Jean Bismuth.

Vascular SVS SCVS The Southern Association for Vascular Surgery CX Symposium

New keynote speaker for VAM (June 19) announced by Vascular SVS
vascularspecialistonline.com/svs-announces-…

Novel microbubble-enhanced ultrasound procedure shows promise in acute porcine DVT model test
vascularspecialistonline.com/novel-microbub…

Johnson & Johnson to acquire Shockwave Medical for $13.1 billion
vascularspecialistonline.com/johnson-johnso…

New data presented at the Society of Interventional Radiology 2024 annual meeting showed that Penumbra Vascular’s Indigo aspiration system used in a single session without the need for overnight tPA is safe and effective for patients with lower extremity ALI vascularspecialistonline.com/new-data-show-…

A new study presented at European Vascular Course by Anna Pouncey (@pounce321) hints at long-term cost-effectiveness of catheter-directed thrombolysis and pharmacochemical thrombectomy over oral anticoagulation for moderate and severe post-thrombotic syndrome vascularspecialistonline.com/study-hints-at…

The 12-month outcomes from a first-in-human study of VETEX Medical's Pounce thrombectomy system in acute iliofemoral deep vein thrombosis recently published in the J Vascular Surgery: Venous and Lymphatic Disorders shows a post-thrombotic syndrome rate of 18.2% vascularspecialistonline.com/first-in-human…